DE2555188C2 - Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe - Google Patents

Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe

Info

Publication number
DE2555188C2
DE2555188C2 DE2555188A DE2555188A DE2555188C2 DE 2555188 C2 DE2555188 C2 DE 2555188C2 DE 2555188 A DE2555188 A DE 2555188A DE 2555188 A DE2555188 A DE 2555188A DE 2555188 C2 DE2555188 C2 DE 2555188C2
Authority
DE
Germany
Prior art keywords
hepatitis
antigen
sample
antibody
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2555188A
Other languages
German (de)
English (en)
Other versions
DE2555188A1 (de
Inventor
William Joseph Ambler Pa. McAleer
William John North Wales Pa. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2555188A1 publication Critical patent/DE2555188A1/de
Application granted granted Critical
Publication of DE2555188C2 publication Critical patent/DE2555188C2/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE2555188A 1974-12-09 1975-12-08 Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe Expired DE2555188C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53102074A 1974-12-09 1974-12-09
US61049975A 1975-09-04 1975-09-04

Publications (2)

Publication Number Publication Date
DE2555188A1 DE2555188A1 (de) 1976-06-10
DE2555188C2 true DE2555188C2 (de) 1982-11-18

Family

ID=27063434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2555188A Expired DE2555188C2 (de) 1974-12-09 1975-12-08 Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe
DE2560402A Expired DE2560402C2 (de) 1974-12-09 1975-12-08 Verfahren zur Herstellung von zur Therapie von Hepatitis A geeignetem, menschlichem Immunserumglobulin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2560402A Expired DE2560402C2 (de) 1974-12-09 1975-12-08 Verfahren zur Herstellung von zur Therapie von Hepatitis A geeignetem, menschlichem Immunserumglobulin

Country Status (5)

Country Link
JP (1) JPS5182721A (enExample)
DE (2) DE2555188C2 (enExample)
FR (1) FR2294446A1 (enExample)
GB (1) GB1508879A (enExample)
NL (1) NL189051C (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
CN101614740B (zh) * 2009-07-30 2013-01-02 杭州艾力康医药科技有限公司 甲型肝炎病毒抗原唾液快速检测试纸条

Also Published As

Publication number Publication date
DE2560402A1 (enExample) 1982-09-23
FR2294446A1 (fr) 1976-07-09
DE2555188A1 (de) 1976-06-10
JPS5182721A (enExample) 1976-07-20
DE2560402C2 (de) 1986-07-10
NL189051B (nl) 1992-07-16
NL7513817A (nl) 1976-06-11
GB1508879A (en) 1978-04-26
FR2294446B1 (enExample) 1979-06-01
NL189051C (nl) 1992-12-16

Similar Documents

Publication Publication Date Title
DE68926300T2 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
DE68922842T2 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
Simpson et al. Spectrophotometric determination of lymphocyte mediated sheep red blood cell hemolysis in vitro
Stockdale et al. Some pathophysiological changes associated with infection of Eimeria zuernii in calves
DE2128670A1 (de) Immunologische Isoenzym Bestimmungs methode
DE3889138T2 (de) Influenza-Impfstoff.
DE2628468C2 (de) Verfahren zur Färbung von Basophilen und Reagens zur Durchführung dieses Verfahrens
EP0279460A1 (de) Virusantigen, Verfahren zu seiner Gewinnung und Anwendung in Diagnose und Therapie (Impfstoff)
DE2531176C3 (de) Verfahren zum Nachweis von Gonorrhoe-Antikörpern
DE3105555C2 (enExample)
DE3879085T2 (de) Snrnp-a-antigen und fragmente davon.
DE2555169C2 (enExample)
DE2555188C2 (de) Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe
CH675636A5 (enExample)
DE2850950B2 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meflreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE2551576B2 (de) Traeger fuer immunochemische messungen
DE2054805C3 (de) Indirekter Hämagglutinationstest bei gleichzeitiger Absorption heterologer Antikörper
DE2521460C2 (de) Verfahren zum Nachweis von Antikörpern gegen Brucella canis und Antigenreagens
DE68911619T2 (de) Reagenz und verfahren zum nachweis von rheumatoiden faktoren.
DE2652091C2 (de) Hämagglutinations-Hemmungstest für Togaviren
DE3116882A1 (de) Stabile form des zur hepatitis b gehoerenden delta-antigens und verfahren zu seiner isolierung
DE69614620T2 (de) Methoden zum Nachweis von menslichem Parvovirus
EP0005243A2 (de) Kontrollplasma, dessen Herstellung, dessen Verwendung zur Ueberwachung der oralen Antikoagulantientherapie sowie Reagenziengarnitur enthaltend dieses Kontrollplasma
DE60118409T2 (de) Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind
DE69132926T2 (de) Diagnostischer test für lyme-krankheit

Legal Events

Date Code Title Description
OD Request for examination
8125 Change of the main classification
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2560402

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2560402

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 2560402

Format of ref document f/p: P